Medical Transcription Billing, Corp. (MTBC) versus HealthEquity (HQY) Critical Survey
Medical Transcription Billing, Corp. (NASDAQ: MTBC) and HealthEquity (NASDAQ:HQY) are both computer and technology companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, earnings, profitability, risk and valuation.
Institutional and Insider Ownership
7.4% of Medical Transcription Billing, Corp. shares are held by institutional investors. Comparatively, 91.0% of HealthEquity shares are held by institutional investors. 53.5% of Medical Transcription Billing, Corp. shares are held by company insiders. Comparatively, 29.0% of HealthEquity shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
Valuation and Earnings
This table compares Medical Transcription Billing, Corp. and HealthEquity’s gross revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Price/Sales Ratio||EBITDA||Earnings Per Share||Price/Earnings Ratio|
|Medical Transcription Billing, Corp.||$30.18 million||1.16||-$2.56 million||($1.08)||-2.81|
|HealthEquity||$202.47 million||14.92||$61.84 million||$0.67||74.54|
HealthEquity has higher revenue and earnings than Medical Transcription Billing, Corp.. Medical Transcription Billing, Corp. is trading at a lower price-to-earnings ratio than HealthEquity, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Medical Transcription Billing, Corp. has a beta of 1.39, meaning that its stock price is 39% more volatile than the S&P 500. Comparatively, HealthEquity has a beta of 1.8, meaning that its stock price is 80% more volatile than the S&P 500.
This table compares Medical Transcription Billing, Corp. and HealthEquity’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Medical Transcription Billing, Corp.||-32.88%||-59.52%||-19.17%|
This is a summary of recent ratings for Medical Transcription Billing, Corp. and HealthEquity, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Medical Transcription Billing, Corp.||0||0||1||0||3.00|
Medical Transcription Billing, Corp. currently has a consensus price target of $2.25, indicating a potential downside of 25.99%. HealthEquity has a consensus price target of $57.00, indicating a potential upside of 14.14%. Given HealthEquity’s higher probable upside, analysts plainly believe HealthEquity is more favorable than Medical Transcription Billing, Corp..
HealthEquity beats Medical Transcription Billing, Corp. on 11 of the 13 factors compared between the two stocks.
Medical Transcription Billing, Corp. Company Profile
Medical Transcription Billing, Corp. is a healthcare information technology company that provides an integrated suite of Web-based solutions, together with related business services, to healthcare providers practicing in ambulatory care settings. The Company’s offering, PracticePro, allows healthcare practices with the core software and business services on Software-as-a-Service (SaaS) platform. PracticePro includes practice management software and related tools, which facilitate the day-to-day operation of a medical practice; electronic health records (EHR), which allow its customers to qualify for government incentives; revenue cycle management (RCM) services, which include medical billing, analytics and related services, and mobile Health (mHealth) solutions, including smartphone applications that assist patients and healthcare providers in the provision of healthcare services. The Company offers a clearinghouse service, which allows clients to track claim status.
HealthEquity Company Profile
HealthEquity, Inc. provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions. Its platform provides an ecosystem where consumers can access their tax-advantaged healthcare savings, compare treatment options and pricing, evaluate and pay healthcare bills, receive personalized benefit and clinical information, earn wellness incentives and make educated investment choices to help in their tax-advantaged healthcare savings. Its products and services include healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements and healthcare incentives. Its ecosystem primarily consists of HSA.
Receive News & Ratings for Medical Transcription Billing Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Transcription Billing Corp. and related companies with MarketBeat.com's FREE daily email newsletter.